Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Aberrant crypt foci.

Alrawi SJ, Schiff M, Carroll RE, Dayton M, Gibbs JF, Kulavlat M, Tan D, Berman K, Stoler DL, Anderson GR.

Anticancer Res. 2006 Jan-Feb;26(1A):107-19. Review.

2.

Aberrant crypt foci as microscopic precursors of colorectal cancer.

Cheng L, Lai MD.

World J Gastroenterol. 2003 Dec;9(12):2642-9. Review.

3.

Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A.

Cell Prolif. 2000 Feb;33(1):1-18. Review.

PMID:
10741640
4.

Aberrant crypt foci as precursors in colorectal cancer progression.

Orlando FA, Tan D, Baltodano JD, Khoury T, Gibbs JF, Hassid VJ, Ahmed BH, Alrawi SJ.

J Surg Oncol. 2008 Sep 1;98(3):207-13. doi: 10.1002/jso.21106. Review.

5.

Inhibition of aberrant crypt foci by chemopreventive agents.

Olivo S, Wargovich MJ.

In Vivo. 1998 Mar-Apr;12(2):159-66. Review.

PMID:
9627797
6.

Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.

Hurlstone DP, Cross SS.

J Gastroenterol Hepatol. 2005 Feb;20(2):173-81. Review.

PMID:
15683417
7.

Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.

Bird RP.

Cancer Lett. 1995 Jun 29;93(1):55-71. Review.

PMID:
7600544
8.

Pre-cancerous lesions for colorectal cancers in rodents: a new concept.

Yamada Y, Mori H.

Carcinogenesis. 2003 Jun;24(6):1015-9. Review.

9.

Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.

Mori H, Yamada Y, Kuno T, Hirose Y.

Mutat Res. 2004 May;566(3):191-208. Review.

PMID:
15082237
10.

[Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].

Katsuki S, Oui M, Takayama T, Takahashi Y, Shuichi N, Niitsu Y.

Nihon Geka Gakkai Zasshi. 1998 Jun;99(6):379-84. Review. Japanese.

PMID:
9695076
11.

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

Gupta AK, Schoen RE.

Curr Opin Gastroenterol. 2009 Jan;25(1):59-65. doi: 10.1097/MOG.0b013e32831db286. Review.

PMID:
19114775
12.

Aberrant crypt foci in colon cancer epidemiology.

Khare S, Chaudhary K, Bissonnette M, Carroll R.

Methods Mol Biol. 2009;472:373-86. doi: 10.1007/978-1-60327-492-0_17. Review.

PMID:
19107443
13.

Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer?

Pretlow TP, Pretlow TG.

Biochim Biophys Acta. 2005 Nov 25;1756(2):83-96. Review.

PMID:
16219426
14.

Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.

Takayama T, Miyanishi K, Hayashi T, Kukitsu T, Takanashi K, Ishiwatari H, Kogawa T, Abe T, Niitsu Y.

Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S42-5. Review.

PMID:
16012995
15.

Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.

Suehiro Y, Hinoda Y.

Cancer Sci. 2008 Jun;99(6):1071-6. doi: 10.1111/j.1349-7006.2008.00784.x. Review.

16.

Aberrant crypt foci: what we know and what we need to know.

Gupta AK, Pretlow TP, Schoen RE.

Clin Gastroenterol Hepatol. 2007 May;5(5):526-33. Review.

PMID:
17433788
17.

Significance and role of early-lesions in experimental colorectal carcinogenesis.

Mori H, Hata K, Yamada Y, Kuno T, Hara A.

Chem Biol Interact. 2005 Jun 30;155(1-2):1-9. Review.

PMID:
15904905
18.

The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer.

Bird RP, Good CK.

Toxicol Lett. 2000 Mar 15;112-113:395-402. Review.

PMID:
10720758
19.

Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma.

Roncucci L.

Ital J Gastroenterol. 1992 Nov-Dec;24(9):498-501. Review.

PMID:
1489980
20.

[Genetics and molecular classification of colorectal cancer].

Søreide K.

Tidsskr Nor Laegeforen. 2007 Nov 1;127(21):2818-23. Review. Norwegian.

Items per page

Supplemental Content

Support Center